RBR-3fthf8进行中（未招募）1 期
Clinical trial phase I/II to evaluate the safety, the neutralizing capacity and the lowest effective dose of antivenom for the treatment of multiple africanized honey bees stings Apis mellifera- APIS Study
Faculdade de Medicina de Botucatu0 个研究点开始时间: 2020年7月26日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 60Y（—）
入选标准
- •Be aged over 18 and under 60 years of both sexes; having a diagnosis of crash with bees Apis; have the consent of the patient or family to receive antivenom.
排除标准
- •Have had frequent contact with products of horse; have had previous adverse reaction to receiving the antivenom; to be pregnant; be with chronic disease, including congenital and acquired immunodeficiencies; introduce diseases that the combined use contraindication antihistamines, corticosteroids and potent analgesics, including allergic reaction.
研究者
相似试验
招募中
1 期
Phase I/IIa trial of Ga-68 PSMA-11 produced on the MPS200 PSMA-Ga automated synthesizerJPRN-jRCT2022230014Shiga Tohru9
进行中（未招募）
1 期
Safety assessment and dose of fibrin sealant derived from snake venom in the treatment of wounds.RBR-9mbdj3Faculdade de Medicina de Botucatu - Unesp
进行中（未招募）
1 期
VAC079; a study to the assess the safety and efficacy of the malaria vaccine PvDBPII in Matrix M1EUCTR2019-002872-14-GBniversity of Oxford / Clinical Trials and Research Governance24
进行中（未招募）
1 期
A study to assess the new malaria vaccine RH5.1/AS01EUCTR2016-001718-31-GBniversity of Oxford, CTRG84
尚未招募
1 期
CIGB-Mambisa/Abdala in convalescentsCOVID-19 ConvalescenceCOVID-19SARS-CoV2Coronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusRPCEC00000382Center for Genetic Engineering and Biotechnology (CIGB)120